| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1998 Oxford University Press
other |
Effect of Glutathione Depletion and Metallothionein Gene Expression on Arsenic-Induced Cytotoxicity and c-myc Expression in Vitro
Laboratory of Comparative Carcinogenesis, National Cancer Institute at the National Institute of Environmental Health Sciences Research Triangle Park, North Carolina 27709
Received November 11, 1997; accepted July 6, 1998
Arsenic exposure is clearly linked to human cancer. In rodent cells, arsenic has been reported to induce aberrant gene expression, including activation of the proto-oncogene c-myc. Abnormal or altered expression of such oncogenes can be involved in the acquisition of a malignant phenotype. Although its mechanism of action is unclear, arsenic is known to exert at least some of its toxic effects through interaction with sulfhydryl groups, and the nonprotein sulfhydryl glutathione (GSH) appears to play an important role in detoxication of arsenic. Similarly, metallothionein (MT), a metal-binding protein with high sulfhydryl content, often functions in defense against metal-induced or oxidative cellular injury. Therefore, we examined the relationship among GSH, MT gene expression, and arsenic-induced toxicity or c-myc expression in cultured rat myoblast (L6) cells. In initial toxicity studies, arsenic was used in both the trivalent (arsenite) and pentavalent (arsenate) forms. The role of GSH was studied by pretreating cells with L-buthionine sulfoximine (BSO), which induces a marked depletion of GSH. In vitro exposure of L6 cells to BSO (1 to 25 µM) resulted in dose-dependent decreases in GSH. GSH depletion sensitized cells to both arsenite and arsenate. Zinc pretreatment, at levels which highly activated MT expression, had no effect on arsenite-induced cytotoxicity. Arsenite (1 µM) alone modestly increased c-myc expression from 1 to 4 h after treatment (maximum of 2.0-fold over control). After GSH depletion cells responded to arsenite exposure with much larger increases in c-myc transcription (3.2-fold over control). Zinc pretreatment had no reductive effect on arsenite-induced c-myc expression despite markedly activating the MT gene. Thus, it appears that the cellular levels of GSH, but not MT gene expression, play an important role in resistance to arsenic toxicity and aberrant gene activation. Moreover, depletion of GSH enhances arsenic-induced proto-on-cogene activation, which might contribute to subsequent transformation.
Key Words: arsenic; arsenite; arsenate; glutathione; metallothionein; c-myc; rat; in vitro.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Rana and T. Allen Influence of thyroxine and n-propylthiouracil on nephro-toxicity of inorganic arsenic in rat Toxicology and Industrial Health, April 1, 2006; 22(3): 137 - 145. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Canovas, R. Vooijs, H. Schat, and V. de Lorenzo The Role of Thiol Species in the Hypertolerance of Aspergillus sp. P37 to Arsenic J. Biol. Chem., December 3, 2004; 279(49): 51234 - 51240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, C. Li, W. Qu, E. Leslie, C. L. Bonifant, G. S. Buzard, J. E. Saavedra, L. K. Keefer, and M. P. Waalkes Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation Mol. Cancer Ther., June 1, 2004; 3(6): 709 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Chen, V. Castranova, Z. Li, M. Karin, and X. Shi Inhibitor of Nuclear Factor {kappa}B Kinase Deficiency Enhances Oxidative Stress and Prolongs c-Jun NH2-Terminal Kinase Activation Induced by Arsenic Cancer Res., November 15, 2003; 63(22): 7689 - 7693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. MOORE, W.-Y. HUANG, J. CHUNG, and R. B. HAYES Epidemiologic Considerations to Assess Altered DNA Methylation from Environmental Exposures in Cancer Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 181 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-S. Bae, C. Gennings, W. H. Carter Jr., R. S. H. Yang, and J. A. Campain Toxicological Interactions among Arsenic, Cadmium, Chromium, and Lead in Human Keratinocytes Toxicol. Sci., September 1, 2001; 63(1): 132 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, H. Chen, D. S. Miller, J. E. Saavedra, L. K. Keefer, D. R. Johnson, C. D. Klaassen, and M. P. Waalkes Overexpression of Glutathione S-Transferase II and Multidrug Resistance Transport Proteins Is Associated with Acquired Tolerance to Inorganic Arsenic Mol. Pharmacol., August 1, 2001; 60(2): 302 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-H. Yih and T.-C. Lee Arsenite Induces p53 Accumulation through an ATM-dependent Pathway in Human Fibroblasts Cancer Res., November 1, 2000; 60(22): 6346 - 6352. [Abstract] [Full Text]
|
|
|
|
|
|
P. P. Simeonova, S. Wang, W. Toriuma, V. Kommineni, J. Matheson, N. Unimye, F. Kayama, D. Harki, M. Ding, V. Vallyathan, et al. Arsenic Mediates Cell Proliferation and Gene Expression in the Bladder Epithelium: Association with Activating Protein-1 Transactivation Cancer Res., July 1, 2000; 60(13): 3445 - 3453. [Abstract] [Full Text]
|
|
|
|
|
|
J. Liu, Y. Liu, R. A. Goyer, W. Achanzar, and M. P. Waalkes Metallothionein-I/II Null Mice Are More Sensitive than Wild-Type Mice to the Hepatotoxic and Nephrotoxic Effects of Chronic Oral or Injected Inorganic Arsenicals Toxicol. Sci., June 1, 2000; 55(2): 460 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Derocq, O. Jbilo, M. Bouaboula, M. Segui, C. Clere, and P. Casellas Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60. POSSIBLE INVOLVEMENT OF THE CB2 RECEPTOR IN CELL DIFFERENTIATION J. Biol. Chem., May 19, 2000; 275(21): 15621 - 15628. [Abstract] [Full Text] [PDF]
|
|